Table 4 Frequency and types of adverse events (AE) during the study period
Etanercept (n = 8)Placebo (n = 9)p Value
Patients with AE (%)10077.8NS
No. of AE2323NS
No. of serious AE33NS
Severity of AE:
    Low62.533.3NS
    Moderate2533.3NS
    Severe12.511.1NS
Type of AE:
    Infections44NS
    Injection site reaction12NS
    Cardiac failure10NS
    Abnormal liver function test21NS
  • NS, not significant.